Cyclazodone is a centrally acting
stimulant
Stimulants (also known as central nervous system stimulants, or psychostimulants, or colloquially as uppers) are a class of drugs that increase alertness. They are used for various purposes, such as enhancing attention, motivation, cognition, ...
drug developed by
American Cyanamid Company in the 1960s. The drug is related to other drugs such as
pemoline and
thozalinone. It displayed a favorable therapeutic index and margin of safety in comparison to pemoline and other N-lower-alkyl-substituted pemoline derivatives.
The patents concluded that cyclazodone possessed properties efficacious in reducing fatigue and as a potential anorectic. Structural congeners of pemoline have been described as "excitants with unique properties distinguishing them from the sympathomimetic amines" whilst displaying less stimulatory activity and toxicity compared to amphetamine.
It is included under the
World Anti-Doping Agency prohibited list.
Safety
Cyclazodone has not been evaluated by the United States Food and Drug Administration for use in humans as a nootropic, anorectic, or stimulant and thus safety information is lacking. However, in studies relating to the therapeutic uses of cyclazodone, it was noted that it exhibited less cardiotoxic and hepatotoxic effects than D-amphetamine in studies on mice.
Synthesis
:

α-Chlorophenylacetyl chloride (1) and 1-cyclopropylurea (2) react to give the
amide (3). The
heterocycle cyclazodone is formed on threatment of this with
sodium ethoxide.
[Najer, H. et al, Bull. Soc. Chim. Fr., 1963, 1810.]
See also
*
Fenozolone
*
Amiphenazole
*
List of aminorex analogues
References
Stimulants
Aminorexes
Norepinephrine-dopamine releasing agents
Oxazolones
{{nervous-system-drug-stub